Table 3.

Diagnostic power of AFP to discriminate patients with HCC from patients with cirrhosis in different three staging systems

Classification	AUC	Sens%	Spe%	PPV%	NPV%	AC%
Number of nodules (n, %)
Single (67, 43.2%)	0.71	22	100	100	53	58
Multiple (88, 56.8)	0.74	31	100	100	52	60
Macrovascular invasion (n, %)
Absent (141, 91%)	0.74	25	100	100	38	48
Present (14, 9%)	0.65	50	100	100	90	91
Size of nodules (n, %)
<2 (48, 31%)	0.72	13	100	100	63	65
>2 (107, 69%)	0.75	33	100	100	49	59
BCLC stage (n, %)
0-A (109, 70.3%)	0.71	19	100	100	41	48
B (46, 29.7)	0.8	52	100	100	75	80
CLIP stage (n, %)
0-1 (122, 79%)	0.69	17	100	100	39	45
2-3 (33, 21%)	0.88	63	100	100	82	86
Okuda stage (n, %)
Stage I (117, 75.5%)	0.67	23	100	100	41	50
Stage II (38, 24.5%)	0.89	39	100	100	70	75